Regulación de la neurotransmisión glicinérgica…
449
32. Sorkina T.; Miranda M.; Dionne K.R.; Hoover B.R.; Zahniser N.R.; Sorkin A. RNA interference
screen reveals an essential role of Nedd4-‐2 in dopamine transporter ubiquitination and
endocytosis. J. Neurosci. 26, 8195-‐205 (2006).
33. González-‐González I.M.; García-‐Tardón N.; Giménez C.; Zafra F. PKC-‐dependent endocytosis
of the GLT1 glutamate transporter depends on ubiquitylation of lysines located in a C-‐
terminal cluster. Glia. 56, 963-‐74 (2008).
34. Fujimuro M.; Yokosawa H. Production of antipolyubiquitin monoclonal antibodies and
their use for characterization and isolation of polyubiquitinated proteins. Methods
Enzymol. 399, 75-‐86 (2005).
35. Zeilhofer H.U. The glycinergic control of spinal pain processing. Cell. Mol. Life. Sci. 62,
2027-‐35 (2005).
36. Yoshikawa S.; Oguchi T.; F
Transporter
Type 2 (GlyT2) Inhibitor
e Behavior in
Rats. Eur. Urol. (2012) DOI:
37. Haranishi Y.; Hara K.; Te
tive effect of
intrathecal administration of glycine transporter-‐2 inhibitor ALX1393 in a rat acute pain
model. Anesth. Analg. 110, 615-‐21 (2010).
38. Chen H.; Polo S.; Di Fiore P.P.; De Camilli P.V. Rapid Ca2+-‐dependent decrease of protein
ubiquitination at synapses. Proc. Natl. Acad. Sci. USA. 100,14908-‐13 (2003).
39. Mukhopadhyay D.; Riezman H. Proteasome-‐independent functions of ubiquitin in
endocytosis and signaling. Science 315, 201-‐5 (2007).
